Serum Antibodies to L-Type Calcium Channels in Patients with Amyotrophic Lateral Sclerosis
NEJM 327:1721-1728, 17521992., Smith,R.G.,et al, 1992
Paraneoplastic Cerebellar Degener III, Cerebellar Degener, Cancer & Lambert-Eaton Myasthenic Synd
Neurol 42:1944-1950, Clouston,P.D.,et al, 1992
Dopamine Agonist Treatment of Fluctuating Parkinsonisn
Arch Neurol 49:560-568, Ahlskog,J.E.,et al, 1992
Acute Respiratory Failure from Dopamine Agonist Withdrawal
Neurol 42:1843-1844, Riley,D.E.,et al, 1992
Tardive Dyskinesia Associated with Use of Metoclopramide in a Child
J Pediatr 121:983-985, Putnam,P.E.,et al, 1992
Ranitidine Pharmacokinetics and Adverse Central Nervous System Reactions
Arch Int Med 152:2325-2329, Slugg,P.H.,et al, 1992
Gangliosides and Neurological Diseases, Their Use in Humans Should be Suspended
BMJ 305:1309-1310, Behan,P.O., 1992
Amyotrophic Lateral Sclerosis and Lymphoma:Bone Marroe Examination and Other Diagnostic Tests
Neurol 42:1101-1102, Rowland,L.P.,et al, 1992
Plasmapheresis in Chronic Demyelinating Polyneuropathy
Letter, NEJM 326:1089-10911992., , 1992
Spinal Cord Syphilis Associated with Human Immunodeficiency Virus Infection:A Treatable Myelopathy
Am J Med 91:101-103, Berger,J.R., 1992
Plasmapheresis and Antineoplastic Treatment in CNS paraneoplastic Syndromes with Antineuronal Autoantibodies
Neurol 42:536-540, Graus,F.,et al, 1992
Striatal D2 Receptor Status in Patients with Parkinson's Disease, Striatonigral Degeneration, and PSP, (PET)
Ann Neurol 31:184-192, Brooks,D.J.,et al, 1992
123I-iodobenzamide-SPECT Predicts Dopaminergic Responsiveness in patients with De Dovo Parkinsonism
Neurol 42:556-561, Schwarz,J.,et al, 1992
Multifocal Motor Neuropathy with Conduction Block:Is It a Distinct Clinical Entity?
Neurol 42:497-505, Lange,D.J.,et al, 1992
An Open-Label Trial of Bromocriptine in Nonfluent Aphasia
Neurol 42:1637-1638, Sabe,L.,et al, 1992
Clinicopath Conf
Churg-Strauss Syndrome, Case 18-1992, NEJM 326:1204-1212992., , 1992
A Multi-Center, Double-Blind Study on Slow-Release Bromocriptine in the Treatment of Parkinson's Disease
Neurol 41:1598-1602, Mannen,T.,et al, 1991
Pleuropulmonary Disease Associated with Dopamine Agonist Therapy
Ann Neurol 30:613-616, Bhatt,M.H.,et al, 1991
The Apomorphine Test in Parkinsonian Syndromes
JNNP 54:870-872, D'Costa,D.F.,et al, 1991
Acute Cerebrovascular Episodes in Systemic Lupus Erythematosus
Quart J Med 293:739-750, Eustace,S.,et al, 1991
Calcium Channel Autoantibodies in the Lambert-Eaton Myashenic Syndrome
Ann Neurol 29:307-314, Leys,K.,et al, 1991
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
Anti-Ri:An Antibody Associated with Paraneoplastic Opsoclonus and Breast Cancer
Ann Neurol 29:241-251, Luque,F.A.,et al, 1991
Treatment of Guillain-Barre Syndrome with Anti-T Cell Monoclonal Antibodies
JNNP 54:51-54, Feasby,T.E., 1991
Aseptic Meningitis Following Cardiac Transplantation:Clinical Characteristics & Relationship to Immunosuppressive Regimen
Neurol 41:249-252, Adair,J.C.,et al, 1991
The Evaluation of Patients with Human Immunodeficiency Virus-Related Disorders and Brain Mass Lesions
Arch Int Med 151:1381-1384, Cimino,C.,et al, 1991
Immunosuppressive Treatment in Multifocal Motor Neuropathy
Ann Neurol 30:397-401, Feldman,E.L.,et al, 1991
Central Nervous System Reactions to Histamine-2 Receptor Blockers
Ann Int Med 114:1027-1034, Cantu,T.G.&Korck,J.S., 1991
Etiology and Management of Single Small CT Lesions in Patients with Seizures:Understanding a Controversy
Acta Neurol Scand 84:465-470, Rajshekhar,V., 1991
Serum Antibodies to GM1 and GM3-gangliosides in Systemic Lupus Erythematosus with Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Acta Neurol Scand 83:399-402, Sindern,E.,et al, 1991
Anti-GM1 IgM Antibodies in Motor Neuron Disease and Neuropathy
Neurol 40:1747-1750, Nobile-Orazio,E.,et al, 1990
Bromocriptine-Induced Hypothermia
Neurol 40:383, Pfeiffer,R.F., 1990
Subcutaneous Apomorphine in the Treatment of Parkinson's Disease
JNNP 53:96-101, Frankel,J.P.,et al, 1990
Nasogastric and Intravenous Infusions of (+) -4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's Disease
JNNP 53:102-105, 1990, Coleman,R.J.,et al, 1990
Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990
Acromegaly
NEJM 322:966-977, Melmed,S., 1990
OKT3 Encephalopathy
Ann Neurol 28:837-838, Coleman,A.E.&Norman,D.J., 1990
Utility of the VDRL Test in HIV-Seropositive Patients
NEJM 322:271, Drabick,J.J.&Tramont,E.C., 1990
Neurotoxicity After Treatment with Muromonab-CD3
NEJM 323:487-488, Richards,J.M.,et al, 1990
Early Findings in the Cerebrospinal Fluid of Patients with HIV-1 Infection of the Central Nervous System
NEJM 323:418-419, Rolfs,A.,et al, 1990
Miller Fisher Syndrome Associated with Q Fever
JNNP 53:615-616, Diaz Ortuno,A.,et al, 1990
The Spectrum of Neurologic Disease Associated with Anti-GM1 Antibodies
Neurol 40:1067-1072, Sadiq,S.A.,et al, 1990
Lower Motor Neuron Disease in a Patient with Autoantibodies Against Gangliosides GM1 and GD1b:Improvement with Immunotherapy
Neurol 40:842-844, Shy,M.E.,et al, 1990
Polyclonal IgM Anti-GM1 Ganglioside Antibody in Patients with Motor Neuron Disease and Variants
Ann Neurol 27:558-563, Salazar-Grueso,E.F.,et al, 1990
Bromocriptine in Parkinson's Disease:A Double-Blind Study Comparing"Low-Slow"and"High-Fast"in de Novo Patients
UK Bromocriptine Res Group, JNNP 52:77-821989., , 1989
Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989
Acute Fatal HIV Encephalitis with Negative Serologic Antibody and Antigen:Diagnosis by Polymerase Chain Reaction
NEJM 320:1494-1495, Varma,V.A.,et al, 1989
Neoplastic Meningitis in Malignant Melanoma:Diagnosis with Monoclonal Antibodies
JNNP 52:881-886, Moseley,R.P.,et al, 1989
Pergolide and Selegiline for Parkinson's Disease
The Medical Letter, 31:81-841989., , 1989
Agonist Substitution in Advanced Parkinson's Disease
Neurol 39:1121-1122, Goetz,C.G.,et al, 1989